Atossa Genetics EBITDA 2012-2025 | ATOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atossa Genetics ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atossa Genetics ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$179.3B
Intuitive Surgical (ISRG)	$175.2B
Alcon (ALC)	$45.3B
Edwards Lifesciences (EW)	$44.5B
IDEXX Laboratories (IDXX)	$44.2B
IQVIA Holdings (IQV)	$34.1B
DexCom (DXCM)	$34B
Mettler-Toledo (MTD)	$26.2B
STERIS (STE)	$22.4B
Waters (WAT)	$17.8B
SONOVA HOLDING (SONVY)	$17.5B
Hologic (HOLX)	$14.7B
Sysmex ADR (SSMXY)	$10.9B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.7B
Globus Medical (GMED)	$7.2B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.1B
Integer Holdings (ITGR)	$3.7B
TransMedics (TMDX)	$3.6B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B
Tandem Diabetes Care (TNDM)	$1B